Engineered Il-18 Secretion and Multi-Antigen Targeting Enable CAR T cells to Eliminate Multiple Myeloma with Low Antigen Expression in an Immunocompetent Mouse Model

Brandon D. Ng Pharmacology Chairperson: Dr. Monica Guzman Major Sponsor: Dr. Marcel van den Brink Minor Sponsors: Dr. David Scheinberg and Dr. Joseph Sun Additional Member: Dr. Renier Brentjens (Roswell Park)